Register      Login
Microbiology Australia Microbiology Australia Society
Microbiology Australia, bringing Microbiologists together
RESEARCH ARTICLE

The role of the gut microbiome in host systems

Clarissa Febinia A , Connie Ha A , Chau Le A and Andrew Holmes A B
+ Author Affiliations
- Author Affiliations

A School of Molecular Bioscience and Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia

B Corresponding author. Email: andrew.holmes@sydney.edu.au

Microbiology Australia 36(1) 14-17 https://doi.org/10.1071/MA15005
Published: 6 March 2015

Abstract

The presence of microbes exerts such a profound influence on animals that they are best considered holobionts – an organism comprised of multiple biological partners. The concept of dysbiosis is disease states that result from undesirable interactions between the partners in a holobiont. Many molecular mechanisms that link the gut microbiome with host health and disease have now been established and these are giving rise to new insights in healthcare. In essence these studies show that our microbiome is so closely intertwined with our physiology that microbiome composition is reflective of many aspects of our health. Of special importance is recognition of the intersection between chronic diet habits and the microbiome in driving changes in our physiological state. In the foreseeable future it is likely microbiome profiling will be a standard diagnostic test in diverse areas of medicine and that interventions targeting the microbiome will be developed.


References

[1]  Stappenbeck, T.S. et al. (2002) Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci. USA 99, 15451–15455.
Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3sXjvVKg&md5=1a1e9ec8c0f8c1c1433c4b91a184e016CAS | 12432102PubMed |

[2]  Cebra, J.J. (1999) Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 69, 1046s–1051s.
| 1:CAS:528:DyaK1MXislGntbk%3D&md5=6120d77dca8db13044a4b40d57c6b71dCAS | 10232647PubMed |

[3]  Rhee, K.-J. et al. (2004) Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J. Immunol. 172, 1118–1124.
Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2cXnvVSh&md5=124adc02478164a0369a92bd1bea6903CAS | 14707086PubMed |

[4]  Lam, Y.Y. et al. (2011) Role of the gut in visceral fat inflammation and metabolic disorders. Obesity (Silver Spring) 19, 2113–2120.
Role of the gut in visceral fat inflammation and metabolic disorders.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXhtlyjs7bP&md5=90241429edeed1b2d37753d63e99d342CAS | 21881620PubMed |

[5]  Bäckhed, F. et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101, 15718–15723.
The gut microbiota as an environmental factor that regulates fat storage.Crossref | GoogleScholarGoogle Scholar | 15505215PubMed |

[6]  Turnbaugh, P.J. et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031.
An obesity-associated gut microbiome with increased capacity for energy harvest.Crossref | GoogleScholarGoogle Scholar | 17183312PubMed |

[7]  LeBlanc, J.G. et al. (2013) Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr. Opin. Biotechnol. 24, 160–168.
Bacteria as vitamin suppliers to their host: a gut microbiota perspective.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38Xht12js77E&md5=25489da3c446eade1ec317a36659fa23CAS | 22940212PubMed |

[8]  Brown, A.J. et al. (2003) The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312–11319.
The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3sXit1Kgsbc%3D&md5=2787d42ba823200796ad0edaed4f4216CAS | 12496283PubMed |

[9]  Licciardi, P.V. et al. (2011) Histone deacetylase inhibition and dietary short-chain Fatty acids. ISRN Allergy 2011, 869647.
Histone deacetylase inhibition and dietary short-chain Fatty acids.Crossref | GoogleScholarGoogle Scholar | 23724235PubMed |

[10]  Kumar, H. et al. (2014) Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. mBio 5.

[11]  Samuel, B.S. et al. (2008) Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl. Acad. Sci. USA 105, 16767–16772.
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXhtlersrvP&md5=2968dad45f2460b5f16d015e922e4829CAS | 18931303PubMed |

[12]  Vijay-Kumar, M. et al. (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228–231.
Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXkt1Cgt7o%3D&md5=7694a3a1f3bbe9b396b89e3a51fcdfb3CAS | 20203013PubMed |

[13]  Ley, R.E. et al. (2008) Worlds within worlds: evolution of the vertebrate gut microbiota. Nat. Rev. Microbiol. 6, 776–788.
Worlds within worlds: evolution of the vertebrate gut microbiota.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXhtFWitLrN&md5=6dab818add424b9f0324ce386f661bf7CAS | 18794915PubMed |

[14]  Swartz, T.D. et al. (2013) Preserved adiposity in the Fischer 344 rat devoid of gut microbiota. FASEB J. 27, 1701–1710.
Preserved adiposity in the Fischer 344 rat devoid of gut microbiota.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXmtFegtbw%3D&md5=820c7c2fd6e281edbdbf78f014159c0aCAS | 23349551PubMed |

[15]  Yatsunenko, T. et al. (2012) Human gut microbiome viewed across age and geography. Nature 486, 222–227.
| 1:CAS:528:DC%2BC38Xos1emtLc%3D&md5=b67ba3c98c472c92bddb9439d84e0c4aCAS | 22699611PubMed |

[16]  Fleissner, C.K. et al. (2010) Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 104, 919–929.
Absence of intestinal microbiota does not protect mice from diet-induced obesity.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXhtFCktL3O&md5=90a4e43e91a9ac57c1717911cee58fd7CAS | 20441670PubMed |

[17]  Zackular, J.P. et al. (2014) The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev. Res. (Phila. Pa.) 7, 1112–1121.
| 1:CAS:528:DC%2BC2cXhvVyjur3J&md5=5ccca942a048d248d02644339746eee8CAS |

[18]  Lawley, T.D. et al. (2012) Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 8, e1002995.
Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38Xhs1OisLbO&md5=1eaeb2b5d7218c3c87a0b88344fb31f5CAS | 23133377PubMed |

[19]  Adamu, B.O. and Lawley, T.D. (2013) Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection. Curr. Opin. Microbiol. 16, 596–601.
Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection.Crossref | GoogleScholarGoogle Scholar | 23866975PubMed |

[20]  Atarashi, K. et al. (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–236.
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXhtFShsbfJ&md5=0dcce03f9c770d0383b9d1e8c6341dabCAS | 23842501PubMed |

[21]  Ryan, K.K. et al. (2014) FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 509, 183–188.
FXR is a molecular target for the effects of vertical sleeve gastrectomy.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXns1Wqsr8%3D&md5=95be88fd77bc21fbc5eaa37aaa781d7cCAS | 24670636PubMed |

[22]  Kennedy, N.A. et al. (2014) The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing. PLoS ONE 9, e88982.
The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing.Crossref | GoogleScholarGoogle Scholar | 24586470PubMed |

[23]  Finucane, M.M. et al. (2014) A taxonomic signature of obesity in the microbiome? Getting to the guts of the matter. PLoS ONE 9, e84689.
A taxonomic signature of obesity in the microbiome? Getting to the guts of the matter.Crossref | GoogleScholarGoogle Scholar | 24416266PubMed |